Diversity and selectivity of receptor-G protein interaction

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 429-459

  Gudermann, Thomas ^a   Kalkbrenner, Frank ^a   Schultz, Günter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

antisense techniques; heptahelical receptors; protein phosphorylation cascades; receptor conformation; signal transduction

Indexed keywords

CYTOKINE; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR;

ARTICLE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0029971060     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.36.040196.002241     Document Type: Article

References (232)

1. Birnbaumer L, Abramowitz J, Brown AM. 1990. Receptor-effector coupling by G proteins. Biochim. Biophys. Acta 1031:163-224
2. Birnbaumer L, Birnbaumer M. 1995. Signal transduction by G proteins: 1994 edition. J. Recept. Signal Transduction Res. 15:213-52
3. Hepler JR, Gilman AG. 1992. G proteins. Trends Biochem. Sci. 17:383-87
4. Neer E. 1995. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249-57
5. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. 1991. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-88
6. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RAF. 1994. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:101-32
7. Baldwin JM. 1994. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6:180-90
8. Donnelly D, Findlay JBC, Blundell TL. 1994. The evolution and structure of aminergic G protein-coupled receptors. Receptors Channels 2:61-78
9. Gudermann T, Nürnberg B, Schultz G. 1995. Receptors and G proteins as primary components of transmembrane signal transduction. I. G-protein-coupled receptors: structure and function. J. Mol. Med. 73:51-63
10. Luttrell LM, Ostrowski J, Cotecchia S, Kendall H, Lefkowitz RJ. 1993. Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptor. Science 259: 1453-57
11. Hawes BE, Luttrell LM, Exum ST, Lefkowitz RJ. 1994. Inhibition of G protein-coupled receptor signaling by ex- pression of cytoplasmic domains of the receptor. J. Biol. Chem. 269: 15776-85
12. Wong SK-F, Ross EM. 1994. Chimeric muscarinic cholinergic: β-adrenergic receptors that are functionally promiscuous among G proteins. J. Biol. Chem. 269:18969-76
13. Wess J, Blin N, Mutschler E, Blüml K. 1995. Muscarinic acetylcholine receptors: structural basis of ligand binding and G protein coupling. Life Sci. 56: 915-22
14. Hofmann KP, Heck M. 1995. Light-induced protein-protein interactions on the rod photoreceptor disc membrane. In Biomembranes II, ed. AG Lee. Greenwich, CT: JAI. In press
15. Simon MI, Strathmann MP, Gautam N. 1991. Diversity of G proteins in signal transduction. Science 252:802-8
16. Noel JP, Hamm HE, Sigler PB. 1993. The 2.2 Å crystal structure of transducin-α complexed with GTPγS. Nature 366:654-63
17. Lambright DG, Noel JP, Hamm HE, Sigler PB. 1994. Structural determinants for activation of a heterotrimeric G protein. Nature 369:621-28
18. 4. Nature 372:276-79
19. iα1 and the mechanism of GTP hydrolysis. Science 265:1405-12
20. αt: more to view than just Ras. Cell 76: 201-4
21. α subunits that interact with Gβγ, receptors, and effectors. Cell 73:631-41
22. Sα. Cell 68:911-22
23. Rarick HM, Artemyev NO, Hamm HE. 1992. A site on rod G protein α subunit that mediates effector activation. Science 256:1031-33
24. αq interacting with PLCβ1 using multiple overlapping synthetic peptides. FEBS Lett. 364:45-50
25. sα reveal a new region important for its activation of adenylyl cyclase. FEBS Lett. 340:249-54
26. Hamm HE, Deretic D, Arendt A, Hargrave PA, Koenig B, Hofmann KP. 1988. Site of G protein binding to rhodopsin mapped with synthetic peptides from the a subunit. Science 241: 832-35
27. i2 chimeras. Biochemistry 34:5544-53
28. Higashijima T, Ross EM. 1991. Mapping of the mastoparan-binding site on G proteins. J. Biol. Chem. 266:12655-61
29. 11 subunits. J. Biol. Chem. 270:21765-71
30. Watson AJ, Katz A, Simon MI. 1994. A fifth member of the mammalian G protein β-subunit family. J. Biol. Chem. 269:22150-56
31. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. 1994. The ancient regulatory-protein family of WD-repeat proteins. Nature 371:297-300
32. Birnbaumer L. 1992. Receptor-to-effector signaling through G proteins: roles for βγ dinners as well as a subunits. Cell. 71:1069-72
33. Clapham DE, Neer EJ. 1993. New roles for G protein βγ-dimers in transmembrane signalling. Nature 365:403-6
34. Peroutka SJ. 1994. Molecular biology of serotonin (5-HT) receptors. Synapse 18:241-60
35. 2-adrenergic receptor. Diabetes 43: 127-36
36. Watson S, Arkinstall S. 1994. The G-Protein Linked Receptor Facts Book. London/San Diego: Academic. 427 pp.
37. s. J. Biol. Chem. 267:15795-801
38. s. Mol. Pharmacol. 41:889-93
39. 2- adrenoceptors. Proc. Natl. Acad. Sci. USA 90:10798-802
40. 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation. Proc. Natl. Acad. Sci. USA 91: 11178-82
41. Gross B, Misrahi M, Sar S, Milgrom E. 1991. Composite structure of the human thyrotropin receptor gene. Biochem. Biophys. Res. Commun. 177:679-87
42. Hecken LL, Daley IJ, Griswold MD. 1992. Structural organization of the follicle-stimulating hormone receptor gene. Mol. Endocrinol. 6:70-80
43. Koo YB, Ji I, Slaughter RG, Ji TH. 1991. Structure of the luteinizing hormone receptor gene and multiple exons of the coding sequence. Endocrinology 128:2297-308
44. Tsai-Morris CH, Buczko E, Wang W, Xie XZ, Dufau ML. 1991. Structural organization of the rat luteinizing hormone (LH) receptor gene. J. Biol. Chem. 266:11355-59
45. Aatsinki JT, Pietilä EM, Lakkakorpi JT, Rajaniemi HJ. 1992. Expression of the LH/CG receptor gene in rat ovarian tissue is regulated by an extensive alternative splicing of the primary transcript. Mol. Cell. Endocrinol. 84:127-35
46. Graves PN, Tomer Y, Davies TF. 1992. Cloning and sequencing of a 1.3 kb variant of human thyrotropin reeptor mRNA lacking the transmembrane domain. Biochem. Biophys. Res. Commun. 187:1135-43
47. Gromoll J, Gudermann T, Nieschlag E. 1992. Molecular cloning of a truncated isoform of the human follicle stimulating hormone receptor. Biochem. Biophys. Res. Commun. 188:1077-83
48. Mayo KE. 1992. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol. Endocrinol. 6: 1734-44
49. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, et al. 1993. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365: 166-70
50. Dittman AH, Weber JP, Hinds TR, Choi EJ, Migeon JC, et al. 1994. A novel mechanism for coupling of m4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: crossover from G protein-coupled inhibition to stimulation. Biochemistry 33: 943-51
51. Migeon JC, Nathanson NM. 1994. Differential regulation of cAMP-mediated gene transcription by m1 and m4 muscarinic acetylcholine receptors. J. Biol. Chem. 269:9767-73
52. 2 receptor. J. Biol. Chem. 269: 19256-61
53. 2 receptor. Nature 349:617-20
54. Zhao D, Yang J, Jones KE, Gerald C, Suzuki Y, et al. 1992. Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. Endocrinology 130: 3529-36
55. De la Peña P, Delgado LM, Del Camino D, Barros F. 1992. Two isoforms of the thyrotropin-releasing hormone receptor generated by alternative splicing have indistinguishable functional properties. J. Biol. Chem. 267:25703-8
56. 1C-adrenoceptor splice variants. FEBS Lett. 363:256-60
57. Lefkowitz RJ, Cotecchia S, Samana P, Costa T. 1993. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci 14:303-7
58. 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268: 4625-36
59. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, et al. 1995. Physiological effects of inverse agonists in transgenic mice with myocardial over-expression of the β2-adrenoceptor. Nature 374:272-76
60. Milligan G, Bond RA, Lee M. 1995. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16:10-13
61. Parma J, Dupret L, Van Sande J, Paschke R, Tonacchera M, et al. 1994. Constitutively active receptors as a disease-causing mechanism. Mol. Cell. Endocrinol. 100:159-62
62. Birnbaumer M. 1995. Mutations and diseases of G protein coupled receptors. J. Recept. Signal Transduction Res. 15: 131-60
63. Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, et al. 1994. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat. Genet. 7:396-401
64. Kopp P, van Sande J, Parma J, Duprez L, Gerber H, et al. 1995. Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N. Engl. J. Med. 332:150-54
65. Hofmann KP, Jäger S, Ernst OP. 1995. Structure and function of activated rhodopsin. Isr. J. Chem. In press
66. Arnis S, Hofmann KP. 1993. Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state. Proc. Natl. Acad. Sci. USA 90:7849-53
67. Arnis S, Fahmy K, Hofmann KP, Sakmar TP. 1994. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269:23879-81
68. Arnis S, Hofmann KP. 1995. Photore-generation of bovine rhodopsin from its signaling state. Biochemistry 34:9333-40
69. q/11. J. Biol. Chem. 269:13733-35
70. 2+ cascades. Mol. Endocrinol. 9:725-33
71. 2+ signaling pathways. FASEB J. 9:A1411 (Abstr.)
72. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, et al. 1993. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-75
73. Rawlings SR. 1994. PACAP, PACAP receptors, and intracellular signaling. Mol. Cell. Endocrinol. 101:C5-C9
74. Robb S, Cheek TR, Hannan FL, Hall LM, Midgley JM, Evans PD. 1994. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J. 13:1325-30
75. Birnbaumer L, Rodbell M. 1969. Adenyl cyclase in fat cells. II. Hormone receptors. J. Biol. Chem. 244:3477-82
76. Rodbell M, Birnbaumer L, Pohl SL. 1970. Adenyl cyclase in fat cells. III. Stimulation by secretin and the effects of trypsin on the receptors for lipolytic hormones. J. Biol. Chem. 245:718-22
77. Offermanns S, Schultz G. 1994. Complex information processing by the transmembrane signaling system involving G proteins. Naunyn Schmiedeberg's Arch. Pharmacol. 350:329-38
78. Ashkenazi A, Winslow JW, Peralta EG, Peterson GL, Schimerlik MI, et al. 1987. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238: 672-75
79. Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J, Capon DJ. 1988. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature 334:434-37
80. 1A receptor. J. Biol. Chem. 264:14848-52
81. 1 protein. Cell. Signal. 3:547-57
82. 1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools. J. Biol. Chem. 266:372-79
83. 1Dβ receptors stably expressed in marine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol. Pharmacol. 44:575-82
84. 2 receptors expressed in different cell types. J. Biol. Chem. 265:10320-26
85. Kubota A, Yamada Y, Kagimoto S, Yasuda K, Someya Y, et al. 1994. Multiple effector coupling of somatostatin receptor subtype SSTR1. Biochem. Biopkys. Res. Commun. 204:176-86
86. Cotecchia S, Kobilka BK, Daniel KW, Nolan RD, Lapetina EY, et al. 1990. Multiple second messenger pathways of α-adrenergic receptor subtypes expressed in eukaryotic cells. J. Biol. Chem. 265:63-69
87. 3 subtype is essential for activation of GTP-binding protein. Eur. J. Biochem. 224:161-66
88. 2. Eur. J. Biochem. 228:23-30
89. Bristol JA, Rhee SG. 1994. Regulation of phospholipase C-β isozymes by G proteins. Trends Endocrinol. Metab. 5: 402-6
90. Exton JH. 1994. Phosphoinositide phospholipases and G proteins in hormone action. Annu. Rev. Physiol. 56:349-69
91. Exton EH. 1996. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:In press
92. Albert PR, Morris SJ. 1994. Antisense knockouts: molecular scalpels for the dissection of signal transduction. Trends Pharmacol. Sci. 15:250-54
93. Camps M, Carozzi A, Schnabel P, Scheer A, Parker P, Gierschik P. 1992. Isozyme-selective stimulation of phospholipase C-β2 by G protein βγ subunits. Nature 60:684-86
94. 2 cascade in CHO cells expressing the human cDNA of the TSH receptor. Mol. Cell. Endocrinol. 74:R1-R6
95. 2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J. Biol. Chem. 267: 4479-88
96. 2+ mobilization by the LH receptor expressed in Xenopus oocytes independent of 3′, 5′-cyclic adenosine monophosphate formation: evidence for parallel activation of two signaling pathways. Mol. Endocrinol. 6:272-78
97. Quintana J, Hipkin RW, Sanchez-Yagüe J, Ascoli M. 1994. Follitropin (FSH) and a phorbol ester stimulate the phosphorylation of the FSH receptor in intact cells. J. Biol. Chem. 269:8772-79
98. Abou-Samra AB, Jüppner H, Force T. Freeman MW, Kong XF, et al. 1992. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc. Natl. Acad. Sci. USA 89:2732-36
99. 2+/inositol phosphate signaling pathways. Mol. Endocrinol. 6:551-56
100. Jelinek LJ, Lok S, Rosenberg GB, Smith RA. Grant FJ, et al. 1993. Expression cloning and signaling properties of the rat glucagon receptor. Science 259: 1614-16
101. Wheeler MB, Lu M, Dillon JS, Leng X-H, Chen C, Boyd III AE. 1993. Functional expression of the rat glucagon-like peptide-1 receptor: evidence for coupling to both adenylyl cyclase and phospholipase C. Endocrinology 133: 57-62
102. Patel DR, Kong Y, Sreedharan SP. 1995. Molecular cloning and expression of a human secretin receptor. Mol. Pharmacol. 47:467-73
103. 1 receptor: selective potentiation by protein kinase A. Mol. Endocrinol. 6: 1815-24
104. Rooney TA, Hager R, Thomas AP. 1991. β-adrenergic receptor-mediated phospholipase C activation independent of cAMP formation in turkey erythrocyte membranes. J. Biol. Chem. 266: 15068-74
105. 2y-purinergic receptors. Biochem. J. 284:917-22
106. s-coupled receptors and dependent on receptor density. Mol. Pharmacol. 46:460-69
107. i, by β-adrenergic receptors in reconstituted phospholipid vesicles. J. Biol. Chem. 259:9351-54
108. o: assay using recombinant a subunits in reconstituted phospholipid vesicles. Biochemistry 30:10769-77
109. James SR, Vaziri C, Walker TR, Milligan G, Downes CP. 1994. The turkey erythrocyte β-adrenergic receptor couples to both adenylate cyclase and phospholipase C via distinct G-protein a subunits. Biochem. J. 304:359-64
110. 3 rat pituitary cells. J. Biol. Chem. 267:24983-88
111. 11. Mol. Endocrinol. 6: 1673-81
112. 3 cells. Proc. Natl. Acad. Sci. USA 90:5587-91
113. 3 rat pituitary tumour cells. Eur. J. Biochem. 204:413-18
114. s couples thyrotropin-releasing hormone receptors expressed in Xenopus oocytes to phospholipase C. J. Biol. Chem. 270: 3554-59
115. 2 and thrombin receptors in human platelets. Proc Natl. Acad. Sci. USA 91:504-8
116. i2 in phospholipid vesicles. Mol. Pharmacol. 46:808-16
117. qα: mutational activation and coupling to receptors and phospholipase C. J. Biol. Chem. 267:31-34
118. i-protein βγ subunits. Nature 356:159-61
119. i2 inhibit cyclic AMP accumulation. Nature 351:63-65
120. z-mediated hormonal inhibition of cyclic AMP accumulation. Science 255:339-42
121. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, et al. 1996. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G-protein families. Proc. Natl. Acad. Sci. USA. In press
122. z? Mol. Cell. Endocrinol. 100:71-74
123. 16 couple a wide variety of receptors to phospholipase C. J Biol Chem. 270:15175-80
124. α16 contribute to the specifictiy of activation by the C5a receptor. Mol. Pharmacol. 47:218-23
125. Neubig RR. 1994. Membrane organization in G-protein mechanisms. FASEB J. 8:939-46
126. Cerione RA, Staniszewski C, Benovic JL, Lefkowitz RJ, Caron M, et al. 1985. Specificity of the functional interactions of the β-adrencergic receptor and rhodopsin with guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J. Biol. Chem. 260:1493-500
127. o is a major growth cone protein subject to regulation by GAP-43. Nature 344:833-41
128. Dym M, Lamsam-Casalotti S, Jia MC, Kleinman HK, Papadopoulos V. 1991. Basement membrane increases G-protein levels and follicle-stimulating hormone responsiveness of sertoli cell adenylyl cyclase activity. Endocrinology 128:1167-76
129. 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of madin-darby canine kidney cells independent of coupling to pertussis toxin-sensitive GTP-binding proteins. J. Biol. Chem. 268:11340-47
130. 2A-adrenergic receptor on the basolateral membrane of madin-darby canine kidney cells. J. Biol. Chem. 269: 16425-33
131. αs that interact with tubulin for β-adrenergic activation of adenylyl cyclase. J. Biol. Chem. 269: 21748-54
132. Roychowdhury S, Rasenick MM. 1994. Tubulin-G protein association stabilizes GTP binding and activates GTPase: cytoskeletal participation in neuronal signal transduction. Biochemistry 33: 9800-5
133. Sargiacomo M, Sudol M, Tang ZL, Lisanti MP. 1993. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolinrich insoluble complex in MDCK cells. J. Cell. Biol. 122:789-807
134. Cohen GB, Ren R, Baltimore D. 1995. Modular binding domains in signal transduction proteins. Cell 80:237-48
135. o. J. Biol. Chem. 266:22285-89
136. sα-Biochemistry 32:11064-73
137. 2 adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 30:3335-41
138. Laugwitz KL, Offermanns S, Spicher K, Schultz G. 1993. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 10:233-42
139. oα selectively associate with the cloned somatostatin receptor subtype SSTR2. J. Biol. Chem. 268: 10721-27
140. iα1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this a subunit necessary for mediating the inhibition by somatostatin of cAMP formation. Mol. Pharmacol. 45:587-90
141. Pronin AN, Gautam N. 1992. Interaction between G protein β and γ subunit types is selective. Proc. Natl. Acad. Sci. USA 89:6220-24
142. Schmidt CJ, Thomas TC, Levine MA, Neer EJ. 1992. Specificity of G protein β and γ subunit interactions. J. Biol. Chem. 267:13807-10
143. Ueda N, Iñiguez-Lluhi JA, Lee E, Smrcka AV, Robishaw JD, Gilman AG. 1994. G protein βγ subunits. J. Biol. Chem. 269:4388-95
144. Wickman KD, Iñiguez-Lluhi JA, Davenport PA, Taussig R, Krapivinsky GB, et al. 1994. Recombinant G protein βγ-subunits activate the muscarinic-gated atrial potassium channel. Nature 368: 255-57
145. Müller S, Hekman M, Lohse MJ. 1993. Specific enhancement of β-adrenergic receptor kinase activity by defined G-protein β and γ subunits. Proc. Natl. Acad. Sci. USA 90:10439-43
146. Phillips WJ, Cerione RA. 1992. Rhodopsin/transducin interactions. I. Characterization of the binding of the transducin-βγ subunit complex to rhodopsin using fluorescence spectroscopy. J. Biol. Chem. 267:17032-39
147. Kelleher DJ, Johnson GL. 1988. Transducin inhibition of light-dependent rhodopsin phosphorylation: evidence for βγ subunit interaction with rhodopsin. Mol. Pharmacol 34:452-60
148. Fawzi AB, Fay DS, Murphy EA, Tamir H, Erdos JJ, Northup JK. 1991. Rhodopsin and the retinal G-protem distinguish among G-protein βγ subunit forms. J. Biol. Chem. 266:12194-200
149. Kisselev O, Gautam N. 1993. Specific interaction with rhodopsin is dependent on the γ subunit type in a G protein. J. Biol. Chem. 268:24519-22
150. Kisselev O, Ermolaeva MV, Gautam N. 1994. A farnesylated domain in the G protein γ subunit is a specific determinant of receptor coupling. J. Biol. Chem. 269:21399-402
151. 1 adrenergic receptor third intracellular loop peptide to Gβ and the amino terminus of Gα. J. Biol. Chem. 269:27618-24
152. Kleuss C, Scherübl H, Hescheler J, Schultz G, Wittig B. 1993. Selectivity in signal transduction determined by γ subunits of heterotrimeric G proteins. Science 259:832-34
153. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, et al. 1993. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268:24543-46
154. Pan MG, Florio T, Stork PJ. 1992. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256:1215-17
155. Florio T, Rim C, Hershberger RE, Loda M, Stork PJ. 1994. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol. Endocrinol. 8:1289-97
156. + currents involves an inhibitory GTP binding protein. Am. J. Physiol. 267:C1389-97
157. 2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J. Biol. Chem. 270:1670-74
158. 2 receptors do not interact with guanine nucleotide binding proteins. Eur. J. Pharmacol. 207:157-63
159. Brechler V, Reichlin S, de Gasparo M, Bottari SP. 1994. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Receptors Channels 2:89-97
160. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. 1995. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 377:744-47
161. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, et al. 1995. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-50
162. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. 1990. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-51
163. Pilon C, Levesque D, Dimitriadou V, Griffon N, Martres MP, et al. 1994. Funcional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol. 268: 129-39
164. Chio CL, Lajiness ME, Huff RM. 1994. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol. Pharmacol. 45:51-60
165. Potenza MN, Graminski GF, Schmauss C, Lemer MR. 1994. Functional expression and characterization of human D2 and D3 dopamine receptors. J. Neurosci. 14:1463-76
166. Davis RJ. 1994. MAPKs: New JNK expands the group. Trends Biochem. Sci. 19:470-73
167. Johnson GL, Vaillancourt RR. 1994. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6:230-38
168. Burgering BMT, Bos JL. 1995. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biol. Sci. 20:18-22
169. ras. Proc. Natl. Acad. Sci. USA 91:12706-10
170. Crespo P, Xu N, Simonds WF, Gutkind JS. 1994. Ras-dependent activation of MAP kinase pathway mediated by G protein βγ subunits. Nature 369:418-20
171. Faure M, Voyno-Yasenetskaya TA, Bourne HR. 1994. cAMP and βγ subunits of heterotrimenc G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269:7851-54
172. Van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, et al. 1995. Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway. Nature 376: 781-84
173. βγ interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem. Sci. 20:151-56
174. Ptasznik A, Traynor-Kaplan A, Bokoch GM. 1995. G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase-Shc adapter protein signaling complexes. J. Biol. Chem. 270:19969-73
175. De Vivo M, Iyengar R. 1994. G protein pathways: signal processing by effectors. Mol. Cell. Endocrinol. 100:65-70
176. Zhong Y. 1995. Mediation of PACAP-like neuropeptide transmission by coactivation of Ras/Raf and cAMP signal transduction pathways in Drosophila. Nature 375:588-92
177. Coso OA, Chiariello M, Kalinec G, Kyriakis JM, Woodgett J, Gutkind JS. 1995. Transforming G protein-coupled receptors potently activate JNK (SAPK). J. Biol. Chem. 270:5620-24
178. 13. J. Biol. Chem. 270: 18655-59
179. Coso OA, Chiariello M, Yu J-C, Teramoto H, Crespo P, et al. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-46
180. Minden A, Lin A, Claret F-X, Abo A, Karin M. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147-57
181. Knaus UG, Morris S, Dong H-J, Chernoff J, Bokoch GM. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269:221-23
182. 1 receptor. Nature 375:247-50
183. Hertel C, Nunnally MH, Wong SKF, Murphy EA, Ross EM, Perkins JP. 1990. A truncation mutation in the avian β-adrenergic receptor causes agonist-induced internalization and GTP-sensitive agonist binding characteristic of mammalian receptors. J. Biol. Chem. 265: 17988-94
184. Wang J, Ross EM. 1995. The carboxyl-terminal anchorage domain of the turkey ßi-adrenergic receptor is encoded by an alternatively spliced exon. J. Biol. Chem. 270:6488-95
185. Houssami S, Findlay DM, Brady CL, Myers DE, Martin TJ, Sexton PM. 1994. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135: 183-90
186. Nussenzveig DR, Thaw CN, Gershengorn MC. 1994. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. J. Biol. Chem. 269: 28123-29
187. Zolnierowicz S, Cron P, Solinas-Toldo S, Fries R, Lin HY, Hemmings BA. 1994. Isolation, characterization, and chromosomal localization of the porcine calcitonin receptor gene. J. Biol. Chem. 269:19530-38
188. Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, et al. 1995. A new type of human calcitonin receptor isoform generated by altenative splicing. Biochem. Biophys. Res. Commun. 209: 744-51
189. 2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-29
190. Giros B, Sokoloff P, Martres M-P, Riou J-F, Emorine LJ, Schwartz J-C. 1989. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342:923-26
191. B subtypes in a heterologous cell line. Mol. Endocrinol. 6:920-26
192. 3 dopamine receptors to G proteins. FEBS Lett. 315:223-26
193. 2 receptors and G-proteins. Mol. Endocrinol. 7:161-70
194. 1 pituitary cells. J. Biol. Chem 269:13880-86
195. 2 dopamine receptor isoforms signal through distinct Giα proteins to inhibit adenylyl cyclase. J. Biol. Chem. 269:23120-27
196. 2 receptor directs specificity of coupling to G-proteins. J. Biol. Chem. 270:7354-58
197. Pin J-P, Waeber C, Prezeau L, Bockaert J, Heinemann S F. 1992. Alternative splicing generates metabotropic glutamate receptors inducing different patterns of calcium release in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 89: 10331-35
198. Fong TM, Anderson SA, Yu H, Huang R-RC, Strader CD. 1991. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 41:24-30
199. Zimprich A, Simon T, Höllt V. 1995. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359: 142-46
200. 3 subtype. J. Biol. Chem. 268:9517-21
201. o. J. Biol. Chem. 268: 26067-70
202. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem. 217:313-18
203. Harazono A, Sugimoto Y, Ichikawa A, Negishi M. 1994. Enhancement of adenylate cyclase stimulation by prostaglandin E receptor EP3 subtype isoforms with different efficiencies. Biochem. Biophys. Res. Commun. 201: 340-45
204. i in cDNA-transfected chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 204:303-9
205. 3 receptor with different carboxyl-terminal domains. J. Biol. Chem. 268:2712-18
206. 2 receptor. J. Biol. Chem. 269: 6163-69
207. Takeuchi K, Takahashi N, Abe T, Ito O, Tsutsumi E, et al. 1994. Functional difference between two isoforms of rat kidney prostaglandin receptor EP3 subtype. Biochem. Biophys. Res. Commun. 203:1897-903
208. 3 prostanoid receptor. FEBS Lett. 338:170-74
209. 2 receptor transduce both intracellular calcium and cAMP signals. Biochemistry 33:14496-502
210. 3 receptors: evidence of three variants with different carboxyl termini. Br. J. Pharmacol. 112:377-85
211. Vanetti M, Vogt G, Höllt V. 1993. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett. 331: 260-66
212. Reisine T, Kong J, Raynor K, Yano J, Takeda J, et al. 1993. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase. Mol. Pharmacol. 44: 1008-15
213. 1-adenosine receptor with recombinant G protein α-subunits. J. Biol. Chem. 266:17778-83
214. 1-adenosine receptor. J. Biol. Chem. 269:32077-84
215. o-like G protein(s). J. Biol. Chem. 269:12954-62
216. 1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry 32:11727-33
217. Parker EM, Kameyama K, Higashijima T, Ross EM. 1991. Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J. Biol Chem. 266:519-27
218. Prather PL, McGinn TM, Erickson LJ, Evans CJ, Loh HH, Law PY. 1994. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J. Biol. Chem. 269: 21293-302
219. z coupling to the rat κ-opioid receptor. FEBS Lett. 360:97-99
220. q/11. Mol. Pharmacol. 45:890-98
221. 2A-adrenergic receptor to multiple G-proteins. J. Biol. Chem. 269: 5730-34
222. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, et al. 1995. Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 16:86-88
223. iα2 suppressed by inducible antisense RNA. Dev. Genet. 14:266-73
224. + current in rat ventromedial hypothalamic neurones. J. Physiol. 474:21-26
225. o proteins functionally coupling galanin receptors to voltage-gated calcium channels. EMBO J. 14: 4728-37
226. i3 Biochem. J. 303:369-75
227. o: antisense oligonucleotide studies. J. Physiol. 470: 1-11
228. Baertschi AJ, Audigier Y, Lledo P-M, Israel J-M, Bockaert J, Vincent J-D. 1992. Dialysis of lactotropes with antisense oligonucleotides assigns guanin nucleotide binding protein subtypes to their channel effectors. Mol. Endocrinol. 6:2257-65
229. Goetzl EJ, Shames RS, Yang J, Birke FW, Liu YF, et al. 1994. Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins. J. Biol. Chem. 269:809-12
230. s protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytes. Nature 358:334-37
231. i2. Science 258:1373-75
232. i2-specific antisense RNA in vivo inhibits neonatal growth. Science 260:991-95